1. Home
  2. Live Updates
  3. Antoine yver

Live Breaking News & Updates on Antoine yver

Stay informed with the latest breaking news from Antoine yver on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Antoine yver and stay connected to the pulse of your community

Temasek-backed Chinese biotech firm D3 Bio raises $62m in Series A+ round

European life sciences investment firm Medicxi led the round with a $40 million investment.

Boyu , Xizang , China , Hongshan , Jiangxi , Shanghai , Chinese , Daiichi-sankyo , George-chen , Antoine-yver , Novartis , Alphabet-inc

Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-3 Study Evaluating SerpinPC for the Treatment of Hemophilia B with Inhibitors

Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-3 Study Evaluating SerpinPC for the Treatment of Hemophilia B with Inhibitors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

London , City-of , United-kingdom , Boston , Massachusetts , United-states , Ukraine , Russia , Kristenk-sheppard , Drug-administration , Nasdaq

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Given Consensus Rating of "Moderate Buy" by Brokerages

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) has earned an average rating of “Moderate Buy” from the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have issued a buy recommendation on […]

Tial-bush , Antoine-yver , Goldman-sachs-group-inc , Centessa-pharmaceuticals , Susquehanna-international-group , Analyst-recommendations-for-centessa-pharmaceuticals , Insider-activity-at-centessa-pharmaceuticals , Centessa-pharmaceuticals-company-profile , Jpmorgan-chase-co , Barclays-plc , Goldman-sachs-group , Nasdaq

Q3 2023 Earnings Estimate for Centessa Pharmaceuticals plc Issued By Leerink Partnrs (NASDAQ:CNTA)

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Free Report) – Leerink Partnrs decreased their Q3 2023 EPS estimates for shares of Centessa Pharmaceuticals in a research note issued to investors on Tuesday, August 15th. Leerink Partnrs analyst D. Risinger now expects that the company will post earnings per share of ($0.45) for the quarter, down from their […]

Tial-bush , Leerink-partnrs , Antoine-yver , Centessa-pharmaceuticals , Centessa-pharmaceuticals-stock-performance , Nasdaq , Susquehanna-international-group , Jpmorgan-chase-co , Goldman-sachs-group , News-ratings-for-centessa-pharmaceuticals-daily , Goldman-sachs-group-inc , Hedge-funds-weigh-in-on-centessa-pharmaceuticals

Centessa Pharmaceuticals plc to Post Q3 2023 Earnings of ($0.45) Per Share, Leerink Partnrs Forecasts (NASDAQ:CNTA)

Centessa Pharmaceuticals plc to Post Q3 2023 Earnings of ($0.45) Per Share, Leerink Partnrs Forecasts (NASDAQ:CNTA)
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Tial-bush , Leerink-partnrs , Antoine-yver , Centessa-pharmaceuticals , Goldman-sachs-group , Nasdaq , News-ratings-for-centessa-pharmaceuticals-daily , Jpmorgan-chase-co , Centessa-pharmaceuticals-stock-down , Prelude-capital-management , Free-report , Centessa-pharmaceutical

Centessa Pharmaceuticals (NASDAQ:CNTA) PT Raised to $5.00 at The Goldman Sachs Group

Centessa Pharmaceuticals (NASDAQ:CNTA) PT Raised to $5.00 at The Goldman Sachs Group
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Antoine-yver , Tial-bush , Centessa-pharmaceuticals-price-performance , Institutional-trading-of-centessa-pharmaceuticals , Centessa-pharmaceuticals , Securities-exchange-commission , Analyst-recommendations-for-centessa-pharmaceuticals , Centessa-pharmaceuticals-company-profile , Goldman-sachs-group , Jpmorgan-chase-co , Blackrock-inc , Barclays-plc

Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 8.4%

Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 8.4%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Tial-bush , Antoine-yver , Jpmorgan-chase-co , Institutional-investors-weigh-in-on-centessa-pharmaceuticals , News-ratings-for-centessa-pharmaceuticals-daily , Securities-exchange-commission , Prelude-capital-management , Barclays-plc , Centessa-pharmaceuticals , Susquehanna-international-group , Nasdaq , Renaissance-technologies

Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume Increase

Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume Increase
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Tial-bush , Antoine-yver , Tanager-wealth-management , Morgan-stanley , Centessa-pharmaceuticals , Centessa-pharmaceuticals-trading-down , Nasdaq , Sio-capital-management , Hedge-funds-weigh-in-on-centessa-pharmaceuticals , News-ratings-for-centessa-pharmaceuticals-daily , Securities-exchange-commission , Get-free-report

Centessa Pharmaceuticals (NASDAQ:CNTA) Trading 11.7% Higher

Centessa Pharmaceuticals (NASDAQ:CNTA) Trading 11.7% Higher
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Antoine-yver , Tial-bush , Nasdaq , Centessa-pharmaceuticals-company-profile , Institutional-trading-of-centessa-pharmaceuticals , Geode-capital-management , Goldman-sachs-group-inc , Tanager-wealth-management , Securities-exchange-commission , News-ratings-for-centessa-pharmaceuticals-daily , Prelude-capital-management , Centessa-pharmaceuticals

Centessa Pharmaceuticals (NASDAQ:CNTA) Price Target Increased to $15.00 by Analysts at BMO Capital Markets

Centessa Pharmaceuticals (NASDAQ:CNTA) Price Target Increased to $15.00 by Analysts at BMO Capital Markets
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Tial-bush , Antoine-yver , Centessa-pharmaceuticals-stock-performance , Centessa-pharmaceuticals , Geode-capital-management , Prelude-capital-management , Insider-activity-at-centessa-pharmaceuticals , Analyst-recommendations-for-centessa-pharmaceuticals , Jpmorgan-chase-co , Centessa-pharmaceuticals-company-profile , Barclays-plc , News-ratings-for-centessa-pharmaceuticals-daily